openPR Logo
Press release

Therapeutic Drug Monitoring Market Forecast 2025: Myriad Genetics, Bayer, Abbott, Thermo Fisher Scientific, Beckman Coulter, bioMérieux, Miraca Life Science, Theradiag, Quest Diagnostics, Merck Millipore, Tecan, Danaher Corporation, MilliporeSigma, Alere

01-08-2019 01:22 PM CET | Health & Medicine

Press release from: Data Bridge Market Research

Therapeutic Drug Monitoring Market

Therapeutic Drug Monitoring Market

Developments, product launches, joint ventures, mergers, and accusations are the moves that the top players in the therapeutic drug monitoring market are making which in turn is affecting the sales, import, export, revenue and CAGR values. This therapeutic drug monitoring report has all the company profiles for the top players and brands and along with that the report further includes a synopsis of market definition, classifications, applications, and market trends. With the help of SWOT analysis, the report has determined the market drivers and restraints.

Global Therapeutic Drug Monitoring Market is expected to reach USD 3.62 Billion by 2025, from USD 2.03 billion in 2017 growing at a CAGR of 7.5 % during the forecast period of 2018 to 2025. The therapeutic drug monitoring market report may be helpful in varied ways that like describing all the moves of the competitive landscape and the way is it poignant in terms of sales, import, export, revenue and CAGR values.

Get Sample Analysis of This Market Information:

This market report defines the market trends and forecast the upcoming opportunities and threats of the therapeutic drug monitoring market in the next 8 years. Therapeutic drug monitoring is measuring the drug concentration in the blood. The main role of this is to regulate the drug dose level in the blood. The main purpose if drug monitoring is to check the efficacy of the drug toxicity and diagnosis. Some of the major players operating in the global therapeutic drug monitoring market are

· Beckman Coulte

· Bio-Rad Laboratories

· F. Hoffmann-La Roche

· Siemens Healthcare

· Thermo Fisher Scientific

· Abbott laboratories

· Bayer AG

· bioMérieux, Inc

· Alere, Inc

· Danaher Corporation

· Theradiag

· Tecan Trading AG

· SQI Diagnostics

· Sekisui Medical Co ltd

· Quest Diagnostics

Other Players are Myriad Genetics, Miraca Life Sciences, Merck Millipore, InSource Diagnostics, Exagen Diagnostics, Euro Diagnostica AB, Diasorinb SPA, Adaptive Biotechnologies, among others. The global therapeutic drug monitoring market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of therapeutic drug monitoring market for global, Europe, North America, Asia Pacific and South America.

The Therapeutic Drug Monitoring market report contains data for historic years 2017, the base year of calculation is 2017 and the forecast period is 2018 to 2025.

· According to 2013 survey by the Medical expenditure panel 1 in 7 American adult takes anti-psychotic drug, which requires therapeutic drug monitoring. Increase in the use of the instruments for drug monitoring level, diagnostic tools in the blood result in the growth of therapeutic drug monitoring market, During the Research and development of cancerous drugs or anti-psychotic drug, drug toxicology and drug bioavailability is done by therapeutic drug monitoring tools.

· As the drug for Cancer, Central nervous system and HIV are very harmful and have many side effects drug monitoring is done in order to check the toxicity, efficacy of the drug. In drug development procedure to check the efficacy and safety of the drug, drug monitoring analysis is done on the animals so that more harmful effects of the drug can be reduced.

· WHO reported that there were 600,000 new cases of resistance to rifamycin among them 490000 had multi drug resistance for TB. As per WHO reports, 36.7 Million were affected from the HIV worldwide at the end of 2016 and 20.9 Million people were receiving the antiretroviral therapy by mid-2017.

Increasing cases of AIDS and Cancer every year, so new, better and more efficacious drug monitoring technologies are required in order to enhance the drug development process.

Get TOC of Full Report:

Major Market Drivers and Restraints:

· New technology and new diseases are expected to drive the market in the forecast period

· Production of new drugs based on new technology.

· Rising geriatric, cancer, HIV population and diabetes

· Increased investment in research and development of membrane devices

· Downward pricing pressure owing to its commodity nature

Market Segmentation: Global Therapeutic Drug Monitoring Market

· The global therapeutic drug monitoring market is segmented based on basis of

• Product
• Technology
• Class of drugs
• Therapeutic areas
• End users
• Geography

· Based on product type, the global therapeutic drug monitoring market is segmented into

• Consumables
• Devices

· Devices are further sub-segmented into Diagnostic devices, proteomic tools.

· Based on the technology, the global therapeutic drug monitoring market is segmented into

• In Immunoassays
• Proteomic technologies

· Immunoassays were further sub-segmented into

• Cloned Enzyme Donor Immunoassay
• Fluorescence Polarization Immunoassay
• Particle-Enhanced Turbidimetric Immunoassay
• Chemiluminescent Immunoassay

· Proteomic technology is further sub-segmented into

• Liquid Chromatography/ Mass Spectrometry
• Gas Chromatography/ Mass Spectrometry

· Based on the class of drugs, the global therapeutic drug monitoring market is segmented into

• Psychoactive Drug
• Bronchodilators
• Immunosuppresants
• Antibiotics
• Antiarrhythmic Drugs
• Anti-Neoplastic Drugs

· Based on the therapy areas, the global therapeutic drug monitoring market is segmented into

• Alimentary Tract And Metabolism
• Blood And Blood Forming Organs
• Cardiovascular Disease
• Dermatological Disease
• Genitourinary Disease And Sex Hormones
• Hormonal Preparations
• Anti-Infectives
• Anti-Neoplastic And Immunomodulating
• Musculo-Skeletal Disease
• Nervous System Disease
• Respiratory Diseases
• Sensory Organ Disease

· On the basis of end users the global therapeutic drug monitoring market is segmented into (hospitals labs, commercial labs and others)

• Hospitals
• Ambulatory Centers
• Clinics
• Community Healthcare

· Based on distribution channel, the global therapeutic drug monitoring market is segmented into

• Retail
• Direct Tenders

· Based on geography, the global therapeutic drug monitoring market report covers data points for 28 countries across multiple geographies namely North America & South America, Europe, Asia-Pacific and, Middle East & Africa.

· Some of the major countries covered in this report are U.S., Canada, Germany, France, U.K., Netherlands, Switzerland, Turkey, Russia, China, India, South Korea, Japan, Australia, Singapore, Saudi Arabia, South Africa and, Brazil among others.

Want Full Report? Enquire Here:

About Us

Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. For Customization and Getting Discount on Report by emailing . We are content with our glorious 99.9 % client satisfying rate.

Contact Us

Data Bridge Market Research
Toll Free: +1-888-387-2818

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Therapeutic Drug Monitoring Market Forecast 2025: Myriad Genetics, Bayer, Abbott, Thermo Fisher Scientific, Beckman Coulter, bioMérieux, Miraca Life Science, Theradiag, Quest Diagnostics, Merck Millipore, Tecan, Danaher Corporation, MilliporeSigma, Alere here

News-ID: 1479634 • Views: 453

More Releases from Data Bridge Market Research

Radiotherapy Market: Global Business Growth And Highest Return On Investment (RO …
Radiotherapy Market analysis report gives us an in-depth overview of the research trends for the financial year 2020. It also provides with important market credentials such as the history, various expansions and trends, trade overview, regional markets, trade and also market competitors. This report studies the Pharmaceutical industry on various parameters such as the raw materials, cost, and technology and consumer preference. Under the analysis on market share by key
Lung Cancer Screening Software Market Competitive Analysis and Top Profiling For …
Lung Cancer Screening Software Market 2019 report analyses the changing trends in the industry. The industry development trends and marketing channels are also analyzed here. In this market document, development policies and plans are discussed as well as manufacturing processes and cost structures are also analyzed. The report offers a detailed analysis of Healthcare IT industry with growth & significant CAGR during forecast period 2019-2026 by top manufacturer's analysis, region,
Elderly Care Market Size, Industry Share, Growth, Trends Analysis 2020, Statisti …
Elderly Care Market 2020 analysis report underlines global leading industry players providing information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact information. Geographically, this report is categorized into various main regions, including sales, proceeds, market share and expansion rate (percent) in the following areas, North America, Asia-Pacific, South America, Europe, Asia-Pacific, The Middle East and Africa. Upstream raw materials and equipment and downstream
Cardiovascular Information Systems Market 2020: May Set New Growth Story | Cerne …
Cardiovascular Information Systems Market 2020 is a professional and comprehensive report covering market parameters about the medical-devices industry. Even more, the report consists of market evolution, market shares, associations and level of investments with other leading companies, monetary settlements impacting the Global Cardiovascular Information Systems Market in recent years are also analyzed. The report pinpoints on the leading market competitors with explaining company profile depending on SWOT analysis to illustrate

All 5 Releases

More Releases for Drug

Biologics Drug Discovery Market
2019-2025 Biologics Drug Discovery Market Report with Depth Analysis The biologics drug discovery involves target identification, hit-to-lead stage, lead identification and optimization. The report presents a comprehensive overview, market size, shares, and growth opportunities of Biologics Drug Discovery market by product type, application, key manufacturers and key regions. Request For Free report Sample - Scope of the Report: Furthermore, Biologics Drug Discovery Market report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers or
Opioid Antagonist Drug Market
The global market has been prognosticated to earn demand from popular types of products such as external use, oral and applications such as household and hospital. The Company has made available another publication in its Healthcare archive of market intelligence reports, which is titled “Global Opioid Antagonist Drug Market Research Report 2018.” While the threat of substitutes and technological risks could have an unfavorable impact on the global market, potential
Drug and cosmetics
Drug and Cosmetics Conferences regards each one of the individuals to go to the On “Drug and Cosmetics” amidst October 17-October 18, 2018 in Toronto, Canada which melds brief keynote presentations, speaker talks, Exhibition, Symposia, Workshops. Drug and Cosmetics Congress is one of the meetings and conferences which will be visited by all the prestigious cosmetologists, Scientists, fiery inspectors, postgraduates, affiliations, business meanders under a solitary rooftop. DRug and cosmetics BLESSY MATHEW Program
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: or +91-11-47067990 Report Table of Contents 1. Introduction to Hepatitis Disease 1.1 Prologue 1.1.1 History of Hepatitis 1.1.2 Causes of Hepatitis Disease 1.2 Types of Viruses which are Responsible for Hepatitis Disease 2. Global Prevalence of Hepatitis Infection 3. Available Drug Classes for Hepatitis Disease Treatment 3.1 Interferon Alfa Therapy 3.2 Protease Inhibitors Therapy 3.3 Polymerase
Microcapsules Drug Delivery Market Microcapsules Drug Delivery Sales Report 2022
For Report Sample Contact: or +91-11-47067990 Report Table of Contents 1. Indispensable Advent of Microcapsules 1.1 Trajectory of Microencapsulation 1.2 Why and wherefores for Microencapsulation 2. Characterization of Microcapsules 2.1 Composition of Microcapsules 2.2 Parameters Influencing Microcapsules 3. Engineering Technology of Microcapsules 3.1 Physical Manufacturing Technologies 3.2 Physicochemical and Chemical Technologies 4. Applicability of Microcapsules 4.1 Microcapsules in Pharmaceuticals 4.2 Microcapsules in Nutraceuticals
AstraZeneca’s NMOSD Drug receives orphan drug designation
April 18, 2017 Orphan Drug European Medicine Agency has Announced orphan drug designation for inebilizumab (earlier known as MEDI-551) developed by AstraZeneca PLC (AZN) for the treatment of neuromyelitis optica spectrum disorder (NMOSD). The drug has already received orphan drug status from US Food and Drug Administration (FDA). NMOSD, also called Devic’s disease, is a rare, autoimmune disorder of the central nervous system (CNS) that affects the functioning